Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Small Cell Lung Carcinoma 9Burkitt Lymphoma 7Lung Neoplasms 6Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Carcinoma, Non-Small-Cell Lung 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large B-Cell, Diffuse 4Sarcoma, Ewing 3Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Plasmablastic Lymphoma 3Multiple Myeloma 3Lymphoma 3Leukemia 3Hodgkin Disease 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Myelodysplastic Syndromes 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Immunoblastic Lymphadenopathy 2HIV Infections 2Ganglioneuroblastoma 2Congenital Abnormalities 2Blast Crisis 2Anemia, Refractory, with Excess of Blasts 2Wilms Tumor 1

Interventions

Vincristine 1Vinblastine 1Topotecan 1Methotrexate 1Induction Chemotherapy 1Etoposide 1Erlotinib Hydrochloride 1Cyclophosphamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Choroid Plexus Neoplasms × Etoposide × 30 days × Clear all
NCT00602667 2026-05-19

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
293 enrolled 89 charts
CNS

Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡